Your browser doesn't support javascript.
loading
Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis.
Schwarz, Carsten; Eschenhagen, Patience; Schmidt, Henrijette; Hohnstein, Thordis; Iwert, Christina; Grehn, Claudia; Roehmel, Jobst; Steinke, Eva; Stahl, Mirjam; Lozza, Laura; Tikhonova, Ekaterina; Rosati, Elisa; Stervbo, Ulrik; Babel, Nina; Mainz, Jochen G; Wisplinghoff, Hilmar; Ebel, Frank; Jia, Lei-Jie; Blango, Matthew G; Hortschansky, Peter; Brunke, Sascha; Hube, Bernhard; Brakhage, Axel A; Kniemeyer, Olaf; Scheffold, Alexander; Bacher, Petra.
Affiliation
  • Schwarz C; Klinikum Westbrandenburg, Campus Potsdam, Cystic Fibrosis Section, Potsdam, Germany.
  • Eschenhagen P; Klinikum Westbrandenburg, Campus Potsdam, Cystic Fibrosis Section, Potsdam, Germany.
  • Schmidt H; Institute of Clinical Molecular Biology, Christian-Albrecht University of Kiel, Kiel, Germany.
  • Hohnstein T; Institute of Immunology, Christian-Albrecht University of Kiel and UKSH Schleswig-Holstein, Kiel, Germany.
  • Iwert C; Department of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Grehn C; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Translational Immunology, Berlin, Germany.
  • Roehmel J; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Steinke E; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt - Universität zu Berlin, Berlin, Germany.
  • Stahl M; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Lozza L; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt - Universität zu Berlin, Berlin, Germany.
  • Tikhonova E; German Center for Lung Research (DZL), associated partner site, Berlin, Germany.
  • Rosati E; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Stervbo U; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt - Universität zu Berlin, Berlin, Germany.
  • Babel N; German Center for Lung Research (DZL), associated partner site, Berlin, Germany.
  • Mainz JG; Cell Biology Laboratory, Precision for Medicine GmbH, Berlin, Germany.
  • Wisplinghoff H; Institute of Clinical Molecular Biology, Christian-Albrecht University of Kiel, Kiel, Germany.
  • Ebel F; Institute of Immunology, Christian-Albrecht University of Kiel and UKSH Schleswig-Holstein, Kiel, Germany.
  • Jia LJ; Institute of Clinical Molecular Biology, Christian-Albrecht University of Kiel, Kiel, Germany.
  • Blango MG; Institute of Immunology, Christian-Albrecht University of Kiel and UKSH Schleswig-Holstein, Kiel, Germany.
  • Hortschansky P; Center for Translational Medicine and Immune Diagnostics Laboratory, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Herne, Germany.
  • Brunke S; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Hube B; Center for Translational Medicine and Immune Diagnostics Laboratory, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Herne, Germany.
  • Brakhage AA; Brandenburg Medical School/Medizinische Hochschule Brandenburg (MHB), University, Pediatric Pulmonology/Cystic Fibrosis, Klinikum Westbrandenburg, Brandenburg an der Havel, Germany.
  • Kniemeyer O; Labor Dr. Wisplinghoff, Cologne, Germany.
  • Scheffold A; Institute for Virology and Microbiology, Witten/Herdecke University, Witten, Germany.
  • Bacher P; Institute for Infectious Diseases and Zoonoses, LMU, Munich, Germany.
J Clin Invest ; 133(5)2023 03 01.
Article in En | MEDLINE | ID: mdl-36701198
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillosis, Allergic Bronchopulmonary / Cystic Fibrosis Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Invest Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillosis, Allergic Bronchopulmonary / Cystic Fibrosis Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Invest Year: 2023 Type: Article Affiliation country: Germany